Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 8/20 | 0.41 |
| ▸ | CA2 | P00918 | 8/20 | 0.41 |
| ▸ | CA9 | Q16790 | 7/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 3/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
| ▸ | CA3 | P07451 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6805213 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL9221661 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL911135 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL187269 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL3332706 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL21581247 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL493840 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL6909601 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL14688826 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL10240 | 0.97 | THRB (0.41) | THRBTSHRMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12597611-B2 | Cathode for an electrochemical cell including at least one cathode additive | DURACELL U.S. OPERATIONS, INC. (US) | 2026-04-07 | — | — | US | claimed |
| US-11075382-B2 | Cathode for an electrochemical cell including at least one cathode additive | DURACELL U.S. OPERATIONS, INC. (US) | 2021-07-27 | — | — | US | claimed |
| CN-106716692-B | Cathode for electrochemical cell comprising at least one cathode additive | 杜拉塞尔美国经营公司 | 2021-01-29 | — | — | CN | claimed |
| EP-3149794-A1 | CATHODE FOR AN ELECTROCHEMICAL CELL INCLUDING AT LEAST ONE CATHODE ADDITIVE | Duracell U.S. Operations, Inc. (US) | 2017-04-05 | — | — | EP | claimed |
| EP-3149140-A1 | WATER CLUSTER-DOMINANT ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | The Procter & Gamble Company (US) | 2017-04-05 | — | — | EP | claimed |
| EP-3149138-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | The Procter & Gamble Company (US) | 2017-04-05 | — | — | EP | claimed |
| EP-3148593-A1 | COMPOSITIONS AND METHODS FOR BIOFILM TREATMENT | THE PROCTER & GAMBLE COMPANY (US) | 2017-04-05 | — | — | EP | claimed |
| EP-3149139-A1 | WATER CLUSTER-DOMINANT ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | The Procter & Gamble Company (US) | 2017-04-05 | — | — | EP | claimed |
| WO-2015184210-A1 | COMPOSITIONS AND METHODS FOR BIOFILM TREATMENT | THE PROCTER & GAMBLE COMPANY (US) | 2015-12-03 | — | — | WO | claimed |
| US-20150349344-A1 | CATHODE FOR AN ELECTROCHEMICAL CELL INCLUDING AT LEAST ONE CATHODE ADDITIVE | DURACELL U.S. OPERATIONS, INC. | 2015-12-03 | — | — | US | claimed |
| WO-2015184211-A1 | WATER CLUSTER-DOMINANT ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY (US) | 2015-12-03 | — | — | WO | claimed |
| WO-2015184209-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY (US) | 2015-12-03 | — | — | WO | claimed |
| WO-2015184212-A1 | WATER CLUSTER-DOMINANT ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY (US) | 2015-12-03 | — | — | WO | claimed |
| US-20150344820-A1 | COMPOSITIONS AND METHODS FOR BIOFILM TREATMENT | THE PROCTER & GAMBLE COMPANY | 2015-12-03 | — | — | US | claimed |
| US-20150344817-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY | 2015-12-03 | — | — | US | claimed |
| US-20150344819-A1 | WATER CLUSTER-DOMINANT ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY | 2015-12-03 | — | — | US | claimed |
| US-20150344818-A1 | WATER CLUSTER-DOMINANT ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY | 2015-12-03 | — | — | US | claimed |
| US-5384410-A | Removal of boronic acid protecting groups by transesterification | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-01-24 | — | — | US | claimed |
| US-12597611-B2 | Cathode for an electrochemical cell including at least one cathode additive | DURACELL U.S. OPERATIONS, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-4401797-A | ADDUCT OF DIHYDROXYPROPYL (METH)ACRYLATE AND BORONIC ACID | SYNTEX (U.S.A.) INC. (US) | 1983-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12597611-B2 | Cathode for an electrochemical cell including at least one cathode additive | EED, SELE, CTNND1 | THRB 763/4885TSHR 3145/4885MEN1 612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.